2 Cell Based Therapies Expert Witnesses Found

Orthopedic Surgery, Medical Devices - Total Knee Replacement, Total Hip Replacement, Robotic-Assisted Total Joint Replacement, Digital Therapeutics, Stem Cell Therapy, Cellular Therapeutics, Molecular Biology, Platelet Rich Plasma therapy, Immunomodulators

...Have written algorithmic based treatment algorithms in machine code. Experience in bench research methods and protocols, quality assurance, inspection and federal requirements, legal and regulatory issues. Specific publication topics include: neuroblastoma, inflammatory cascades and wound healing properties in transgenic mice, liver failure support models, fetal wound healing, necrotizing enterocolitis, near-infrared spectroscopy, negative pressure therapy, growth factors, immunomodulators, hip fracture fixation, digital rehabilitation, artificial Intelligence, orthopaedic trauma, humerus fractures, ulnar nerve biology, ivc filter placement, deep vein thrombosis, limb threatening injuries, intramedullary fixation, thromboelastography, renal tumors, wilms tumor, radiofrequency ablation, neutrophils, fetal endothelial cells, complex traumatic wounds, vascularized bone grafting, free flap grafting.

Regenerative Medicine, Biomedical Engineering - Regenerative Medicine, Cellular Therapies, Stem Cells, Extracellular Matrix, Perinatal Tissues (Placenta, Amnion, Chorion, Umbilical Cord Blood/Tissue), Transplantation, Cellular & Tissue Engineering, Biotechnology, Bioengineering, Medical Devices, Tissue Processing/Banking, HSCs, MSCs

...Taghizadeh has dedicated more than 20 years to bringing stem cell-based therapies to clinical practice. His expertise in adult stem cells, primarily human hematopoietic and mesenchymal stem cells—the regenerative cells involved in successful bone marrow and umbilical cord blood transplantations—uniquely positions him to approach science and business with the same keen powers of insight that have consistently reaped success surmounting scientific and medical barriers in the field. He earned his Ph.D. in Stem Cell Bioengineering in 2006 from the Massachusetts Institute of Technology (MIT) and co-founded AuxoCell Laboratories, Inc. as Chief Scientific Officer in 2008 after completing his post-doctoral training from MIT and the Boston Biomedical Research Institute. At MIT, in the laboratory of Dr. James L. Sherley, Dr....